GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Thelma Therapeutics (XKRX:015540) » Definitions » Ending Cash Position

Thelma Therapeutics (XKRX:015540) Ending Cash Position : ₩121 Mil (As of Sep. 2022)


View and export this data going back to 1989. Start your Free Trial

What is Thelma Therapeutics Ending Cash Position?

Thelma Therapeutics's Ending Cash Position for the quarter that ended in Sep. 2022 was ₩121 Mil.

Thelma Therapeutics's quarterly Ending Cash Position declined from Mar. 2022 (₩50 Mil) to Jun. 2022 (₩49 Mil) but then increased from Jun. 2022 (₩49 Mil) to Sep. 2022 (₩121 Mil).

Thelma Therapeutics's annual Ending Cash Position increased from Dec. 2019 (₩963 Mil) to Dec. 2020 (₩1,914 Mil) but then declined from Dec. 2020 (₩1,914 Mil) to Dec. 2021 (₩250 Mil).


Thelma Therapeutics Ending Cash Position Historical Data

The historical data trend for Thelma Therapeutics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thelma Therapeutics Ending Cash Position Chart

Thelma Therapeutics Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 276.19 1,182.74 962.63 1,913.97 249.91

Thelma Therapeutics Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 581.91 249.91 50.13 49.26 121.41

Thelma Therapeutics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Thelma Therapeutics's Ending Cash Position for the fiscal year that ended in Dec. 2021 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=1913.971+-1664.06
=250

Thelma Therapeutics's Ending Cash Position for the quarter that ended in Sep. 2022 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=49.255+72.152
=121


Thelma Therapeutics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Thelma Therapeutics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Thelma Therapeutics (XKRX:015540) Business Description

Traded in Other Exchanges
N/A
Address
Mapo-gu, Seoul Sangam DMC Prugio City, 25, World Cup Buk-ro 54-gil, Seoul, KOR
Thelma Therapeutics, formerly Medipartner Biotechnology is a South Korean company engaged in providing hospital management support, dental material distribution, medical devices manufacturing, and development of new materials.

Thelma Therapeutics (XKRX:015540) Headlines

No Headlines